LETITIA COVACI: Open Payments
NPI 1316069560 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 16 payments from 5 companies in 2025. Trend: 2023 $854 · 2024 $1,309 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $305 |
| Otsuka America Pharmaceutical, Inc. | 9 | $286 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
Products named: CAPLYTA, ABILIFY MAINTENA, INGREZZA, ABILIFY ASIMTUFII, COBENFY, LYBALVI.
Industry payments across PA — which companies pay providers there.
